University of California

Universities and colleges

Islet Transplantation in Type 1 Diabetics Using a Novel Immunouspressive Regimen

Researchers from the University of California have successfully conducted islet transplantation in type 1 diabetics using a novel immunosuppressive regimen based on the anti-LFA-1 antibody efalizumab. This study demonstrated that insulin independence after islet transplantation can be achieved with a corticosteroid- and calcineurin inhibitor-free regimen, which may minimize renal and